These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 25071868)

  • 21. P21-activated kinase 4 regulates the cyclin-dependent kinase inhibitor p57(kip2) in human breast cancer.
    Li Y; Wang D; Zhang H; Wang C; Dai W; Cheng Z; Wang G; Li F
    Anat Rec (Hoboken); 2013 Oct; 296(10):1561-7. PubMed ID: 23873832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigen p57/Kip2 as a potential negative regulator of human astrocytoma growth.
    Akaishi K; Nakayama J; Sakai K; Kobayashi T; Rutka JT
    J Clin Neurosci; 2009 Dec; 16(12):1615-8. PubMed ID: 19822429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CDK inhibitor p57 (Kip2) is negatively regulated by COP9 signalosome subunit 6.
    Chen B; Zhao R; Su CH; Linan M; Tseng C; Phan L; Fang L; Yang HY; Yang H; Wang W; Xu X; Jiang N; Cai S; Jin F; Yeung SC; Lee MH
    Cell Cycle; 2012 Dec; 11(24):4633-41. PubMed ID: 23187808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CyclinD1 and p57
    Ru Y; Chen XJ; Zhao ZW; Zhang PF; Feng SH; Gao Q; Gao SG; Feng XS
    Oncotarget; 2017 Sep; 8(43):73860-73870. PubMed ID: 29088752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of multiple cell cycle regulatory functions of p57Kip2 in human T lymphocytes.
    Li G; Domenico J; Lucas JJ; Gelfand EW
    J Immunol; 2004 Aug; 173(4):2383-91. PubMed ID: 15294951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C/EBPbeta Promotes transition from proliferation to hypertrophic differentiation of chondrocytes through transactivation of p57.
    Hirata M; Kugimiya F; Fukai A; Ohba S; Kawamura N; Ogasawara T; Kawasaki Y; Saito T; Yano F; Ikeda T; Nakamura K; Chung UI; Kawaguchi H
    PLoS One; 2009; 4(2):e4543. PubMed ID: 19229324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The developmental expression of the CDK inhibitor p57(kip2) (Cdkn1c) in the early mouse placenta.
    Saunders AC; McGonnigal B; Uzun A; Padbury J
    Mol Reprod Dev; 2016 May; 83(5):405-12. PubMed ID: 26988311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Down-regulation of p57Kip2 induces prostate cancer in the mouse.
    Jin RJ; Lho Y; Wang Y; Ao M; Revelo MP; Hayward SW; Wills ML; Logan SK; Zhang P; Matusik RJ
    Cancer Res; 2008 May; 68(10):3601-8. PubMed ID: 18483241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of p15INK⁴b and p57KIP² and relationship with clinicopathological features and prognosis in patients with vulvar squamous cell carcinoma.
    Holm R; Førsund M; Nguyen MT; Nesland JM; Trope CG
    PLoS One; 2013; 8(4):e61273. PubMed ID: 23580324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Beckwith-Wiedemann-Associated
    Stampone E; Bencivenga D; Barone C; Di Finizio M; Della Ragione F; Borriello A
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical analysis of P57(kip2), p53 and hsp60 expressions in premalignant and malignant oral tissues.
    Fan GK; Chen J; Ping F; Geng Y
    Oral Oncol; 2006 Feb; 42(2):147-53. PubMed ID: 16246616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High Skp2/Low p57(Kip2) Expression is Associated with Poor Prognosis in Human Breast Carcinoma.
    Yang C; Nan H; Ma J; Jiang L; Guo Q; Han L; Zhang Y; Nan K; Guo H
    Breast Cancer (Auckl); 2015; 9(Suppl 1):13-21. PubMed ID: 26309408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Cdk inhibitor p57(Kip2) controls LIM-kinase 1 activity and regulates actin cytoskeleton dynamics.
    Vlachos P; Joseph B
    Oncogene; 2009 Nov; 28(47):4175-88. PubMed ID: 19734939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic and Epigenetic Control of CDKN1C Expression: Importance in Cell Commitment and Differentiation, Tissue Homeostasis and Human Diseases.
    Stampone E; Caldarelli I; Zullo A; Bencivenga D; Mancini FP; Della Ragione F; Borriello A
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29614816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p57(KIP2) expression in normal islet cells and in hyperinsulinism of infancy.
    Kassem SA; Ariel I; Thornton PS; Hussain K; Smith V; Lindley KJ; Aynsley-Green A; Glaser B
    Diabetes; 2001 Dec; 50(12):2763-9. PubMed ID: 11723059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age-dependent changes of p57(Kip2) and p21(Cip1/Waf1) expression in skeletal muscle and lung of mice.
    Park CW; Chung JH
    Biochim Biophys Acta; 2001 Aug; 1520(2):163-8. PubMed ID: 11513958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of p57(KIP2) in hepatocellular carcinoma: relationship between tumor differentiation and patient survival.
    Nakai S; Masaki T; Shiratori Y; Ohgi T; Morishita A; Kurokohchi K; Watanabe S; Kuriyama S
    Int J Oncol; 2002 Apr; 20(4):769-75. PubMed ID: 11894123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cell cycle inhibitor p57(Kip2) promotes cell death via the mitochondrial apoptotic pathway.
    Vlachos P; Nyman U; Hajji N; Joseph B
    Cell Death Differ; 2007 Aug; 14(8):1497-507. PubMed ID: 17464323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new ubiquitin ligase involved in p57KIP2 proteolysis regulates osteoblast cell differentiation.
    Kim M; Nakamoto T; Nishimori S; Tanaka K; Chiba T
    EMBO Rep; 2008 Sep; 9(9):878-84. PubMed ID: 18660753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p57(Kip2) stabilizes the MyoD protein by inhibiting cyclin E-Cdk2 kinase activity in growing myoblasts.
    Reynaud EG; Pelpel K; Guillier M; Leibovitch MP; Leibovitch SA
    Mol Cell Biol; 1999 Nov; 19(11):7621-9. PubMed ID: 10523650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.